Apellis Pharmaceuticals, Inc. (APLS)

NASDAQ: APLS · IEX Real-Time Price · USD

37.98

+0.03 (0.08%)

At close: Jul 19, 2024, 4:00 PM

37.96

-0.02 (-0.05%)

Pre-market: Jul 22, 2024, 8:52 AM EDT

Apellis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Cash & Equivalents	327.03	352.3	553.07	641.76	567.05	351.99	Upgrade
Short-Term Investments	0	0	0	60.36	311.87	0	Upgrade
Cash & Cash Equivalents	327.03	352.3	553.07	702.11	878.91	351.99	Upgrade
Cash Growth	-57.33%	-36.30%	-21.23%	-20.12%	149.70%	99.69%	Upgrade
Receivables	267.84	206.44	7.73	10.1	0	0	Upgrade
Inventory	161.28	146.36	85.71	16.29	0	0	Upgrade
Other Current Assets	55.28	61.23	73.01	95.55	38.28	21.11	Upgrade
Total Current Assets	811.43	766.33	719.52	824.05	917.19	373.1	Upgrade
Property, Plant & Equipment	19.19	21.09	24.9	26.08	24.52	15.77	Upgrade
Other Long-Term Assets	1.31	1.31	15.8	31.64	18.86	0.39	Upgrade
Total Long-Term Assets	20.5	22.4	40.69	57.72	43.38	16.15	Upgrade
Total Assets	831.93	788.73	760.22	881.77	960.57	389.25	Upgrade
Accounts Payable	26.79	37.52	37.34	16.91	8.48	8.36	Upgrade
Deferred Revenue	3.56	0	0	0	0	0	Upgrade
Current Debt	6.26	6.44	5.63	4.12	3.69	2.61	Upgrade
Other Current Liabilities	178.69	203.64	124.64	110.82	116.17	54.78	Upgrade
Total Current Liabilities	215.29	247.59	167.61	131.85	128.33	65.75	Upgrade
Long-Term Debt	102.88	104.49	107.09	206.11	374.05	154.42	Upgrade
Other Long-Term Liabilities	247.08	242.13	315.65	345.15	253.64	134.84	Upgrade
Total Long-Term Liabilities	349.96	346.62	422.74	551.26	627.69	289.26	Upgrade
Total Liabilities	565.25	594.21	590.35	683.1	756.01	355.02	Upgrade
Total Debt	109.14	110.93	112.71	210.22	377.73	157.03	Upgrade
Debt Growth	-2.44%	-1.58%	-46.38%	-44.35%	140.54%	480.65%	Upgrade
Retained Earnings	-2,903.91	-2,837.49	-2,308.86	-1,656.69	-926.35	-581.47	Upgrade
Comprehensive Income	-3.53	-3.54	-0.88	-2.09	-0.12	-0.15	Upgrade
Shareholders' Equity	266.68	194.52	169.87	198.66	204.56	34.23	Upgrade
Net Cash / Debt	217.89	241.37	440.36	491.89	501.18	194.95	Upgrade
Net Cash / Debt Growth	-66.71%	-45.19%	-10.48%	-1.85%	157.08%	30.64%	Upgrade
Net Cash Per Share	1.77	2.03	4.15	5.83	6.67	3.13	Upgrade
Working Capital	596.14	518.74	551.91	692.2	788.87	307.34	Upgrade
Book Value Per Share	2.17	1.64	1.60	2.35	2.72	0.55	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).